Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus C... (Lilly undertakeno duty to update forward...)

(Date:11/26/2009)...outh Africa, Nov. 26 The 2009 Fros...Award in the Generic Pharmaceutical Market is pres...(Logo: http://www.newscom.com/cgi-bin/prnh/200811...d, the following criteria were used to benchmark C... growth strategy and implementation, degree of inn...

(Date:11/25/2009)...Nov. 25 Hologic, Inc. (H... developer, manufacturer and supplier of premium d...roducts dedicated to serving the healthcare needs ...logical Society of North America (RSNA) at McCormi...3, 2009 to highlight our new SecurView(®) DX ...

(Date:11/25/2009)...5 BioTrends Research Group, Inc. r...ara report, the first in a multi-phase syndicate...entocor Ortho-Biotech,s Stelara, from product laun...Each wave of the report provides quantitative info...ive information from a subset of 20. The reports ...

Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2 Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3 Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4 New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2 New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3 New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4 Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2 In Letter to Congress NORD Urges Action on Healthcare Reform 53373 1 In Letter to Congress NORD Urges Action on Healthcare Reform 53373 2 In Letter to Congress NORD Urges Action on Healthcare Reform 53373 3 Scientists decoding genomic sequences of H1N1 using isolates from outbreak in Argentina 9445 1 Scientists decoding genomic sequences of H1N1 using isolates from outbreak in Argentina 9445 2 Minority and Womens Advocacy Groups Send Letter to California Attorney General Jerry Brown Requesting Investigation Into Discrimination by Health Insu 53368 1 Minority and Womens Advocacy Groups Send Letter to California Attorney General Jerry Brown Requesting Investigation Into Discrimination by Health Insu 53368 2 Minority and Womens Advocacy Groups Send Letter to California Attorney General Jerry Brown Requesting Investigation Into Discrimination by Health Insu 53368 3 Minority and Womens Advocacy Groups Send Letter to California Attorney General Jerry Brown Requesting Investigation Into Discrimination by Health Insu 53368 4

[0] Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market [0] New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity [0] Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High

...HINGTON, Sept. 17 The Department of,Justice annou...he CEO,Roundtable on Cancer (CRC) to develop and p...ls of potential new cancer treatments. The Departm...etitive and can be used to help,increase efficienc...osts,and shortening the time needed to begin clini...

... and TORONTO, Sept. 17 Sanofi pasteur, the,vaccin... today that it is,sponsoring a Phase II clinical s...to high risk and advanced-stage melanoma -- an oft...d treatment options. Patients are being,enrolled i...MEL11, will,investigate the safety and efficacy of...

Other Medicine Technology:Justice Department Will Not Oppose CEO Roundtable on Cancer's Proposal 2 Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 2 Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 3 Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 4 Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 5

Justice Department Will Not Oppose CEO Roundtable on Cancer's Proposal Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients

(Date:11/26/2009)...27 With cold and flu season upon u...actices to control the spread of infections and av...ly to keep ourselves healthy, but to avoid transmi... RN, MS, CIC (certified in infection-control), nur...al health at Hospital for Special Surgery (HSS) in...

(Date:11/26/2009)... number of Americans living with diabetes will nea...o 44.1 million in 2034. Over the same period, spen...113 billion to $336 billion, even with no increase...t the University of Chicago report in the December... with diabetes covered by Medicare will rise from ...

(Date:11/26/2009)...oo heavy can lead to strains or worse , ,...be nothing wrong with stuffing your turkey full to...hing with your suitcase as you pack for holiday tr...2008 in U.S. hospital emergency rooms, doctors, of...ggage-related injuries, such as muscle strains, pu...

(Date:11/26/2009)...o more letters from the North Pole, Textsanta.net ...s from Santa , North Pole...al efficiencies at the North Pole Santa Claus has ... over the globe informed of his Christmas progress...earch department have identified a large and growi...

(Date:11/26/2009)...esearch Triangle Dental (RTDental), a leading dent... announced the expansion of its services to includ...oug Macmillan. , Durha...ed to announce that Dr. Doug Macmillan, an experie...ditional advanced training seminar. RTDental&rsqu...

Breaking Medicine News(10 mins):Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4 Health News:Diabetes cases to double and costs to triple by 2034 2 Health News:Diabetes cases to double and costs to triple by 2034 3 Health News:Pack Right for the Holidays to Avoid the ER 2 Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2 Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2

[1] Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use [0] Diabetes cases to double and costs to triple by 2034 [2] Pack Right for the Holidays to Avoid the ER [1] Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes [0] Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental

...SAN CARLOS, Calif., Nov. 6 Nektar,Therapeutics (N...ased 32%, or,$100.0 million, of its outstanding co...ollar, for a total purchase price of $47.8 million...argely complete," said Nektar,President and CEO Ho...

...MK-677 brought muscle mass, but long-term effects ...URSDAY, Nov. 6 (HealthDay News) -- An experimenta...owth hormone in seniors to youthful levels, a new ...d to significant improvements in their strength or...

...Third quarter revenues increase 65 percent versus ... at 4:30 p.m. Eastern Time Today, IRVINE, Calif.,...worldwide leader in intravascular temperature,mana...months ended September 30, 2008., Revenue for the...

...Quarterly Revenue Exceeds $10 Million Company Del...tember, BEDFORD, Mass., Nov. 6 Insulet Corporati...nology with its OmniPod(R),Insulin Management Syst...lion compared to,$3.8 million in the third quarter...

..., Atlanta, Ga. November 06, 2008 Down syndrome,...mpairment, occurs in approximately 1-in-700 births...cent of fetuses with Down syndrome are lost before...urrent knowledge of Down syndrome, identify inform...

...STEWARTVILLE, Minn., Nov. 6 Rochester Medical,Cor...g results for its fourth,quarter and year ended Se...les of $9,512,000 for the current quarter,compared...733,000 or $.06 per diluted share for the fourth q...

Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results Drug Boosts Natural Growth Hormone in Seniors Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress Insulet Reports Third Quarter 2008 Results Experts discuss future of public health research on Down syndrome Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales

...meter trial lens set has consistently been the mar...g only the highest level of quality throughout the...ns set continues to set the standard for excellenc...o the guidelines established by highly recognized ...

Non-Illuminated Trial Lens Set

Trial Lens Sets

L'Anthony's Desaturated 15 Hue Test

Medicine Products:

35-6 TW Trial Lens Set Non-Illuminated Trial Lens Set Trial Lens Sets L'Anthony's Desaturated 15 Hue Test

Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus C...(Lilly undertakeno duty to update forward...),Health